Nature Communications (Oct 2024)

Discovery and prioritization of genetic determinants of kidney function in 297,355 individuals from Taiwan and Japan

  • Hung-Lin Chen,
  • Hsiu-Yin Chiang,
  • David Ray Chang,
  • Chi-Fung Cheng,
  • Charles C. N. Wang,
  • Tzu-Pin Lu,
  • Chien-Yueh Lee,
  • Amrita Chattopadhyay,
  • Yu-Ting Lin,
  • Che-Chen Lin,
  • Pei-Tzu Yu,
  • Chien-Fong Huang,
  • Chieh-Hua Lin,
  • Hung-Chieh Yeh,
  • I-Wen Ting,
  • Huai-Kuang Tsai,
  • Eric Y. Chuang,
  • Adrienne Tin,
  • Fuu-Jen Tsai,
  • Chin-Chi Kuo

DOI
https://doi.org/10.1038/s41467-024-53516-7
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 16

Abstract

Read online

Abstract Current genome-wide association studies (GWAS) for kidney function lack ancestral diversity, limiting the applicability to broader populations. The East-Asian population is especially under-represented, despite having the highest global burden of end-stage kidney disease. We conducted a meta-analysis of multiple GWASs (n = 244,952) on estimated glomerular filtration rate and a replication dataset (n = 27,058) from Taiwan and Japan. This study identified 111 lead SNPs in 97 genomic risk loci. Functional enrichment analyses revealed that variants associated with F12 gene and a missense mutation in ABCG2 may contribute to chronic kidney disease (CKD) through influencing inflammation, coagulation, and urate metabolism pathways. In independent cohorts from Taiwan (n = 25,345) and the United Kingdom (n = 260,245), polygenic risk scores (PRSs) for CKD significantly stratified the risk of CKD (p < 0.0001). Further research is required to evaluate the clinical effectiveness of PRSCKD in the early prevention of kidney disease.